Vital Farms Faces a Pivotal Moment as Legal Challenges Mount and Institutional Investors Circle

Vital Farms faces shareholder lawsuits and a 50% stock drop after a botched ERP rollout, but institutional ownership at 98.6% signals long-term confidence.

Vital Farms is navigating one of the most turbulent periods in its history, caught between a wave of shareholder lawsuits and the quiet confidence of institutional investors who have been increasing their stakes. The egg producer’s stock has been battered over the past four months, yet the company’s long-term growth story continues to attract heavyweight backers.

A Bumpy Road Paved by Software Woes

The root of the current crisis can be traced to a botched enterprise resource planning (ERP) system rollout. Multiple US law firms have filed securities fraud claims against the company, alleging that management failed to disclose the severity of the implementation problems. The operational fallout was significant: production outages and delivery delays led to lost shelf space in retail stores, and only in February 2026 did executives acknowledge the struggle to reclaim those positions.

The financial damage became visible in the fourth quarter of 2025. Earnings per share came in at $0.35, narrowly missing analyst estimates, while revenue reached approximately $214 million. Since the start of the year, the stock has shed more than half its value, hitting a 2026 low of €10.38 in late April — equivalent to roughly $11.80.

Institutional Investors Double Down

Despite the turmoil, professional money managers remain heavily committed. Fifth Third Bancorp and Citizens Financial Group both adjusted their holdings in early May, and institutions now control a staggering 98.6 percent of the company’s shares. That level of institutional dominance suggests that sophisticated investors are looking past the current operational headaches toward the underlying business.

Analysts broadly share that view. The average price target among 14 covering the stock stands at about $37, implying substantial upside from current levels around $12. The bull case rests on Vital Farms’ brand strength and its presence in 24,000 US supermarkets.

Growth Story Intact, But Margins Under Pressure

The company continues to expand its top line. Full-year 2025 net revenue rose more than 25 percent to $759 million, while net profit climbed to $66 million. For the first quarter of 2026, due for release in May, analysts forecast revenue of roughly $184 million — a 13 percent year-over-year increase.

The earnings picture is less rosy. Estimates for first-quarter EPS range from just $0.08 to $0.13, reflecting margin compression from heavy discounting and the lingering effects of the ERP disruption. Management is sticking with its full-year target of up to $920 million in revenue, but the market will be watching closely to see whether the IT issues are truly behind the company.

A Critical Test Ahead

The upcoming quarterly report will serve as a major inflection point. If Vital Farms can demonstrate that its operational problems are resolved, the stock could find a floor. The company has also been investing in marketing, launching a “Good Eggs Diner” campaign aimed at cementing its leadership in the premium egg segment.

The legal clock is ticking as well. The deadline for shareholders to join the class-action lawsuits is May 26, 2026, adding another layer of uncertainty. With the stock trading well below its long-term average of $26.40, the next few weeks will determine whether this is a buying opportunity or a value trap.